NCT07858461Not yet recruiting
Subclinical Gastrointestinal Involvement in Juvenile Systemic Lupus Erythematosus
Evaluation of Subclinical Gastrointestinal Involvement in Juvenile Systemic Lupus Erythematosus at Assiut University Children Hospital
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
This cross-sectional case-control study aims to evaluate fecal calprotectin levels and intestinal ultrasound findings for the detection of subclinical gastrointestinal involvement in children with juvenile systemic lupus erythematosus compared with healthy controls.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 29 Sept 2026
- Start date
- 30 Sept 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Assiut University
- Diseases
- Lupus (SLE)
- NCT number
- NCT07858461
What you commit to
- Study type: Observational
- Planned participants: 60
- From 30 Sept 2026 to the primary completion date, 30 Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- Established diagnosis of inflammatory bowel disease or other primary gastrointestinal disorder
- Significant gastrointestinal manifestations (persistent abdominal pain, diarrhea, vomiting, GI bleeding, significant unexplained weight loss)
- Active gastrointestinal infection within the preceding 4 weeks
- Other autoinflammatory or overlapping autoimmune diseases
- Chronic liver or renal disease unrelated to JSLE
Other
- Antibiotics, probiotics, or NSAIDs within the 2 weeks preceding stool sample collection
Who the study is looking for
- Children less than 18 years of age
- Diagnosis of juvenile systemic lupus erythematosus according to SLICC criteria
- Disease duration of at least 3 months
- Age- and sex-matched healthy controls
- Written informed consent from parents or legal guardians
Age in the registry: 1 year to 18 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.